Co-Diagnostics announced that last month the Board of Directors appointed Richard Abbott as President of Co-Diagnostics, Inc., concurrent with the company naming David Nielsen to be its Chief Operations Officer, Christopher Thurston as its Chief Technology Officer, and Seth Egan as Chief Commercialization Officer. Prior to his new role at the Company, Richard Abbott served as the President of Advanced Conceptions, Inc., a wholly-owned subsidiary of Co-Diagnostics since December 2021.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CODX:
- Co-Diagnostics CEO Dwight Egan delivers manufacturing, commercialization update
- Co-Diagnostics Inc Welcomes Richard Abbott as New President
- Co-Diagnostics price target lowered to $2.50 from $3 at H.C. Wainwright
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
- Co-Diagnostics reports cash, equivalents of $58.5M as of December 31, 2023